Randomized study comparing simultaneous injection with sequential injection of Fulvestrant
Phase 2
- Conditions
- Postmenopausal breast cancer
- Registration Number
- JPRN-UMIN000009563
- Lead Sponsor
- Yokohama City University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients who are impossible to be enrolled with psychological diseases or disorder 2)Inappropriate patients by investigator' decision
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) Visual analog scales for simultaneous and sequential injections of Fulverant 2) Patient choice of injection method of Fulverant for 3rd time and after
- Secondary Outcome Measures
Name Time Method 1) Time for injections 2) Questionnaire to patients regarding each injection method 3) Questionnaire to nurses regarding each injection method